EUCTR2011-004609-26-FR进行中（未招募）不适用
Evaluation of the efficacy and safety of two methadone titration methods for the treatment of cancer-related pain with inadequate pain relief or intolerable side effects when treated with level 3 opioids. - EQUIMETH2
aboratoires Bouchara-Recordati0 个研究点目标入组 161 人开始时间: 2011年10月6日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 161
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Adult patient of at least 18 years of age
- •2. Patient suffering from cancer disease, undergoing chemotherapy treatment or not
- •3. Patient presenting nociceptive or mixed pains inadequately relieved with level 3 opioids (morphine, oxycodone, transdermal fentanyl, hydromorphone) with a numeric pain scale score =5 evidence-based or presenting intolerable side effects with level 3 opioids
- •4. Patient undergoing level 3 opioid treatment (morphine sulphate or morphine chlorhydrate or fentanyl or oxycodone or hydromorphone)
- •5. Patient presenting a good understanding of the study objectives and able to give his/her written consent
- •6. Patient able to communicate with the investigator or his representative
- •7. Patient available during the whole course of the study and agreeing the study requirements
- •8. Patient with Social Insurance
- •9. Patient having received patient’s information form, orally informed and having signed the consent form.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 80
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 81
排除标准
- •1. Patient in terminal cancer disease (life expectancy less than 2 months) according to investigator’s judgement
- •2. Patient treated with a medication that may result in an interaction with methadone, such as: antiarrythmic treatments (Ia or III), erythromycin, spiramycin, intravenous vincamin
- •3. Patient receiving opioid treatment for any other reason than pain
- •4. Patient unable to swallow the study treatment
- •5. Patient presenting contra-indication to the use of methadone
- •6. Patient having a decompensated respiratory failure or a severe hepatic disease
- •7. Patient having a known hypersensitivity to methadone
- •8. Patient presenting QT interval prolongation on ECG results
- •9. Patient receiving a concomitant treatment with a morphine-type agonist-antagonist medication (pentazocine, buprenorphine, nalbuphine) or with sultropide
- •10. Patient treated by radiotherapy within 15 days before inclusion
- •11. Patient participating or having participated in another clinical trial with a new therapy within 1 month before inclusion
- •12. Patient with a history of substance abuse
- •13. For woman with childbearing potential: pregnancy or breastfeeding.
- •14. Forfeiture of freedom or under guardianship
- •15. Past history of suicidal attempts
- •16. Patient likely not to respect the study conditions and/or study discontinuation criteria according to investigator’s judgement
- •17. Patient presenting any other medical condition or illness or clinically significant abnormal findings on the physical examination at screening that, in the opinion of the Investigator, make the patient unsuitable for the study or put the patient at additional risk.
研究者
相似试验
已完成
4 期
A clinical trial to study the effects of two drugs, Metformin Immediate Release and Metformin Extended Release in newly diagnosed type 2 diabetes mellitus patients.CTRI/2021/04/033194Bangalore Medical College and Research Institute70
进行中（未招募）
不适用
To evaluate the effectiveness of MetaDerm Cream in Atopic DermatitisCTRI/2017/06/008950Haus Bioceuticals Inc
已完成
3 期
Comparison of the effectiveness of drug treatment and elastic band therapy in the treatment of hemorrhoidsIRCT20210630051748N1Esfahan University of Medical Sciences60
尚未招募
不适用
To evaluate the efficacy of two drugs methylprednisolone and etoricoxib in laproscopic surgeryCTRI/2019/03/018041Department of anaesthesiology Jln Medical College ajmer
已完成
3 期
Comparison of therapeutic effect of prolotherapy by glucose, corticosteroid and physical therapy in shoulder teddinopathyIRCT20101113005172N4Shahid Beheshti University of Medical Sciences114